Billionaire Profile
Ye Chenghai & family
Global Rank
#1085

Image: Unsplash Contributor | Unsplash License | via Unsplash

Ye Chenghai & family

CEO, Pharmaceuticals
HONG KONG
Real-Time Net Worth
$3.944B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+7.56% (24h)
Age
82
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
HONG KONG

Biography

Ye Chenghai is a prominent figure in the Chinese pharmaceutical industry, with an estimated net worth of $2.2 billion as of the most recent available data. Born on August 15, 1943, Ye's career began in politics before transitioning to business. He served as the Vice Mayor of Shenzhen before entering the pharmaceutical sector. Ye's wealth is primarily derived from his role as the Chairman of Shenzhen Salubris Pharmaceuticals, a company specializing in cardiovascular, anti-infection, and anticancer drugs. His career exemplifies a successful shift from public service to entrepreneurship, leading to significant achievements in China's healthcare industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Political Career

Ye Chenghai was born in Meizhou, Guangdong, China, on August 15, 1943. He pursued studies in international politics at Renmin University of China. After graduating in 1968, he was assigned to Bao'an County, which later became Shenzhen. He held several positions in Shenzhen, including a member of the municipal party standing committee, party secretary of Luohu District, and Vice Mayor of Shenzhen.

Rise to Success

In 1985, Ye Chenghai resigned from his government position and ventured into business. He founded Shenzhen Salubris Pharmaceuticals, which has become a leading pharmaceutical company in China. Under his leadership, the company has experienced significant growth and success, specializing in the research, development, and production of pharmaceutical products, contributing greatly to the healthcare sector. Ye Chenghai's son, Kevin, currently serves as the CEO of Shenzhen Salubris Pharmaceuticals.

Key Business Strategies

Ye Chenghai's primary business strategy involved leveraging his understanding of the Chinese market and government policies to build a successful pharmaceutical company. His ability to transition from a political background to a business environment proved crucial. The company focused on producing drugs that cater to major health issues, like cardiovascular diseases, which allowed it to secure a strong market position.

Philanthropy

Ye Chenghai has shown a commitment to philanthropy. In April 2024, Renmin University of China announced the establishment of the Chenghai Institute for Global Development and Security, which was funded by a donation from Ye.

Career Milestones

1968

Graduated from Renmin University of China

Obtained a degree in international politics.

1985

Founded Shenzhen Salubris Pharmaceuticals

Transitioned from politics to business and established the company.

2024

Philanthropic Initiative

Funded the establishment of the Chenghai Institute for Global Development and Security at Renmin University of China.

Philanthropy & Social Impact

Education and Global Security

Chenghai Institute for Global Development and Security

$XB

Funded the establishment of an institute at Renmin University of China.